
Inozyme
Biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases.
Market cap
$258m
Enterprise value
$220m
Share price
$4.00 INZY
Authorizing premium user...
Biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases.